Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active

Takashi Shimada, Itaru Urakawa, Tamara Isakova, Yuji Yamazaki, Michael Epstein, Katherine Wesseling-Perry, Myles Wolf, Isidro B. Salusky, Harald Jüppner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

178 Scopus citations

Fingerprint

Dive into the research topics of 'Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds